Originator: Tulane University
First marketed by: Merck Serono
Name of FDF: Cetrotide®
Original FDF: Powder for reconstitution and IV injection
Other FDF: RTU solution for subcutaneous injection
Mode of Action
Gonadotropin releasing hormone inhibitors. It competes with natural GnRH for binding to membrane receptors on pituitary cells and thus controls the release of LH and FSH in a dose-dependent manner.
Female infertility. It is used to prevent luteinizing hormone surges in women undergoing assisted reproduction therapy.
Generic products are available